New data show that the addition of Herceptin (trastuzumab) to chemotherapy prior to breast cancer surgery (neoadjuvant therapy) completely eradicates tumours in nearly three times as many women with …

OctoPlus N.V. announced that it has acquired exclusive worldwide rights to develop and commercialise a family of compounds, including a GLP-1 agonist product candidate for the treatment of type 2 …

A consortium of experts in the field of human virus research and vaccine development have joined forces to develop a novel pandemic influenza vaccine as a potential emergency vaccination. The …

Affibody Holding AB has received a letter from the Swedish Medical Product Agency (MPA) allowing it to begin an exploratory clinical trial of a new approach for diagnosing an aggressive form of …

Price and volume explosion..Click for details

Price and volume explosion..Click for details

Signals are generated for tomorrows markets based on todays closing prices and daily statistics.

Dr. Stewart Sell, a member of BioCurex’s Scientific Advisory Board, has been awarded the prestigious ISOBM-Abbott award for his lifetime achievements in cancer research, immunology, developmental …

MorphoSys AG announced that the U.S. Patent & Trademark Office has granted a fifth U.S. patent stemming from MorphoSys’s base HuCAL (Human Combinatorial Antibody Library) patent family, providing …

Collaboration focuses on development and global commercialization of a molecular diagnostic test for the early detection of colorectal cancer.Abbott obtains non-exclusive worldwide rights to …